AIM - AIM ImmunoTech Inc.


0.0949
-0.023   -24.025%

Share volume: 2,305,517
Last Updated: 04-04-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.01%

PREVIOUS CLOSE
CHG
CHG%

$0.12
-0.02
-0.19%
This ticker is disabled and data are no longer maintained and up to date.
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2024
Fiscal Quarter Q4 2024
Report Date 03-27-2025
Total revenue 45.000 K
Cost of revenue 0.000
Gross profit 45.000 K
     
Operating expenses 5.893 M
Selling general and admin 4.229 M
Research and development 1.664 M
Total expenses 5.900 M
     
Operating income -5.855 M
Ebit -5.936 M
Pretax income -6.257 M
     
Income tax 0.000
Net income basic 0.000
     
Net income -5.967 M